“…This plan implies 80% affordability of essential cancer drugs and medicine by the year 2020 worldwide [5]. Today in 2017, after 4 years of the 7 years plans, there is no sign of any remarkable progress toward achievement of the objective.If the movement continue in the same way of reports, conferences, commissions, task forces , that end with reporting the tragic situation and data, with calls and plans of actions to improve the picture by 2020 0r 2025 , but without focused and globally coordinated scientific works to explore unlimited approaches to resource sparing and cost effective care and with shortage of practical tactics that consider the incentives and interests of all stakeholders and mobilisation of every possible resources ; financial and human resources and allies in win-win scenarios that cope with the real world, then it is expected that the problem will tragically escalate in the upcoming 10 years particularly in LMICs [6]. In addition to the lack of foreseen remarkable increase of radiotherapy and medical oncology services, there are -among others causes-the increase in cancer incidence and prevalence in LMICs partially due to increase in population, increase of life expectancy , lower mortality due to communicable in comparison to non-communicable diseases and change of life style [7,8].…”